Pseudogenes are functionless relatives of genes that have lost their gene expression in the cell or their ability to code protein. Pseudogenes often result from the accumulation of multiple mutations within a gene whose product is not required for the survival of the organism. Although not protein-coding, the DNA of pseudogenes may be functional, similar to other kinds of noncoding DNA which can have a regulatory role.
Although some pseudogenes do not have introns or a promoter (these pseudogenes are copied from messenger RNA and incorporated into the chromosome and are called processed pseudogenes), most have some gene-like features such as promoters, CpG islands, and splice sites. They are different from normal genes due to a lack of protein-coding ability resulting from a variety of disabling mutations (e.g. premature stop codons or frameshifts), a lack of transcription, or their inability to encode RNA (such as with ribosomal RNA pseudogenes). The term was coined in 1977 by Jacq et al.
Because pseudogenes are generally thought of as the last stop for genomic material that is to be removed from the genome, they are often labeled as junk DNA. A pseudogene can be operationally defined as a fragment of nucleotide sequence that resembles a known protein's domains but with stop codons or frameshifts mid-domain. Nonetheless, pseudogenes contain biological and evolutionary histories within their sequences. This is due to a pseudogene's shared ancestry with a functional gene: in the same way that Darwin thought of two species as possibly having a shared common ancestry followed by millions of years of evolutionary divergence, a pseudogene and its associated functional gene also share a common ancestor and have diverged as separate genetic entities over millions of years.
Pseudogenes are characterized by a combination of homology to a known gene and nonfunctionality. That is, although every pseudogene has a DNA sequence that is similar to some functional gene, they are nonetheless unable to produce functional final protein products. Pseudogenes are sometimes difficult to identify and characterize in genomes, because the two requirements of homology and nonfunctionality are usually implied through sequence alignments rather than biologically proven.
- Homology is implied by sequence identity between the DNA sequences of the pseudogene and parent gene. After aligning the two sequences, the percentage of identical base pairs is computed. A high sequence identity (usually between 40% and 100%) means that it is highly likely that these two sequences diverged from a common ancestral sequence (are homologous), and highly unlikely that these two sequences have evolved independently (see Convergent evolution).
- Nonfunctionality can manifest itself in many ways. Normally, a gene must go through several steps to a fully functional protein: Transcription, pre-mRNA processing, translation, and protein folding are all required parts of this process. If any of these steps fails, then the sequence may be considered nonfunctional. In high-throughput pseudogene identification, the most commonly identified disablements are premature stop codons and frameshifts, which almost universally prevent the translation of a functional protein product.
Pseudogenes for RNA genes are usually more difficult to discover as they do not need to be translated and thus do not have "reading frames".
Types and origin
There are three main types of pseudogenes, all with distinct mechanisms of origin and characteristic features. The classifications of pseudogenes are as follows:
Processed (or retrotransposed) pseudogenes. In higher eukaryotes, particularly mammals, retrotransposition is a fairly common event that has had a huge impact on the composition of the genome. For example, somewhere between 30% - 44% of the human genome consists of repetitive elements such as SINEs and LINEs (see retrotransposons). In the process of retrotransposition, a portion of the mRNA transcript of a gene is spontaneously reverse transcribed back into DNA and inserted into chromosomal DNA. Although retrotransposons usually create copies of themselves, it has been shown in an in vitro system that they can create retrotransposed copies of random genes, too. Once these pseudogenes are inserted back into the genome, they usually contain a poly-A tail, and usually have had their introns spliced out; these are both hallmark features of cDNAs. However, because they are derived from a mature mRNA product, processed pseudogenes also lack the upstream promoters of normal genes; thus, they are considered "dead on arrival", becoming non-functional pseudogenes immediately upon the retrotransposition event. However, these insertions occasionally contribute exons to existing genes, usually via alternatively spliced transcripts. A further characteristic of processed pseudogenes is common truncation of the 5' end relative to the parent sequence, which is a result of the relatively non-processive retrotransposition mechanism that creates processed pseudogenes. Processed pseudogenes are continuously being created primates. Humans populations, for example, have distinct sets of processed pseudogenes across its individuals.
Non-processed (or duplicated) pseudogenes. Gene duplication is another common and important process in the evolution of genomes. A copy of a functional gene may arise as a result of a gene duplication event and subsequently acquire mutations that cause it to become nonfunctional. Duplicated pseudogenes usually have all the same characteristics as genes, including an intact exon-intron structure and promoter sequences. The loss of a duplicated gene's functionality usually has little effect on an organism's fitness, since an intact functional copy still exists. According to some evolutionary models, shared duplicated pseudogenes indicate the evolutionary relatedness of humans and the other primates. If pseudogenization is due to gene duplication, it usually occurs in the first few million years after the gene duplication, provided the gene has not been subjected to any selection pressure. Gene duplication generates functional redundancy and it is not normally advantageous to carry two identical genes. Mutations that disrupt either the structure or the function of any one of the two genes are not deleterious and will not be removed through the selection process. As a result, the gene that has been mutated gradually becomes a pseudogene and will be either unexpressed or functionless. This kind of evolutionary fate is shown by population genetic modeling and also by genome analysis. According to evolutionary context, these pseudogenes will either be deleted or become so distinct from the parental genes so that they will no longer be identifiable. Relatively young pseudogenes can be recognized due to their sequence similarity.
Various mutations can stop a gene from being successfully transcribed or translated, and a gene may become nonfunctional or deactivated if such a mutation becomes fixed in the population. This is the same mechanism by which non-processed genes become deactivated, but the difference in this case is that the gene was not duplicated before becoming disabled. Normally, such gene deactivation would be unlikely to become fixed in a population, but various population effects, such as genetic drift, a population bottleneck, or in some cases, natural selection, can lead to fixation. The classic example of a unitary pseudogene is the gene that presumably coded the enzyme L-gulono-γ-lactone oxidase (GULO) in primates. In all mammals studied besides primates (except guinea pigs), GULO aids in the biosynthesis of ascorbic acid (vitamin C), but it exists as a disabled gene (GULOP) in humans and other primates. Another interesting and more recent example of a disabled gene links the deactivation of the caspase 12 gene (through a nonsense mutation) to positive selection in humans.
Pseudogenes can complicate molecular genetic studies. For example, amplification of a gene by PCR may simultaneously amplify a pseudogene that shares similar sequences. This is known as PCR bias or amplification bias. Similarly, pseudogenes are sometimes annotated as genes in genome sequences.
Processed pseudogenes often pose a problem for gene prediction programs, often being misidentified as real genes or exons. It has been proposed that identification of processed pseudogenes can help improve the accuracy of gene prediction methods.
It has also been shown that the parent sequences that give rise to processed pseudogenes lose their coding potential faster than those giving rise to non-processed pseudogenes.
By definition, pseudogenes lack a functioning gene product. However, classification of pseudogenes generally relies on computational analysis of genomic sequences. This has led to the misclassification of some coding genes as pseudogenes. Examples include
- The Drosophila jingwei gene, a functional, chimeric gene which was once thought to be a processed pseudogene.
- Makorin1 (MKRN1). A retrotransposed pseudogene has been identified whose transcript purportedly plays a trans-regulatory role in the expression of its homologous gene, Makorin1 (MKRN1) (see also RING finger domain and ubiquitin ligases), and suggested this as a general model under which pseudogenes may play an important biological role. However, the original findings concerning Makorin1 have recently been contested;
- Phosphoglycerate mutase 3 (PGAM3P). A processed pseudogene called phosphoglycerate mutase 3 (PGAM3P) actually produces a functional protein.
- siRNAs. Some endogenous siRNAs appear to be derived from pseudogenes, and thus some pseudogenes play a role in regulating protein-coding transcripts.
- piRNAs. Some Piwi-interacting RNAs (piRNAs) are derived from pseudogenes located in piRNA clusters. Those pseudogenes regulate their founding source genes via the piRNA pathway in mammalian testes.
- PTENP1 and KRAS1P (KRASP1). The mRNA levels of tumour suppressor PTEN and oncogenicKRAS is affected by their homologous pseudogenes PTENP1 and KRASP1. A miRNA decoy function for this pseudogene in cancer has been identified.
Involvement in cancer
Although pseudogenes have been dismissed as being nonfunctional and not worthy of extensive study in the past, they have recently been associated to various diseases and functions, one of which is cancer development. In fact, pseudogenes have recently been associated with the long non-coding RNA family (DeMartino et al., 2016). Rather than having no function, pseudogenes seem to be involved in various mechanisms, ranging from acting as miRNA decoys, to reducing DNA binding affinity, to enhancing activity of transcription factors.
Pseudogenes related to the PTEN gene were found to be heavily involved in cancer development. The PTEN protein is a known tumor suppressor, and reduction of its expression results in increased cell growth and proliferation. The PTEN pseudogene, PTENP1 is a processed pseudogene that is very similar in its genetic sequence to the wild-type PTEN gene. However, PTENP1 has a missense mutation in the starting methionine that blocks translation of the gene into the PTEN mRNA, and consequently prevents coding of the PTEN protein as well (Poliseno et al., 2010). Although PTENP1 cannot be transcribed, it may still play a role in development. The 3’ UTR functions as a decoy of PTEN targeting miRNAs due to its similarity to the PTEN gene, and overexpression of the 3’ UTR resulted in an increase of PTEN protein level (Poliseno et al., 2010). That is, overexpression of the PTENP1 3’ UTR leads to increased regulation and suppression of cancerous tumors. Although the exact mechanisms are not yet known, PTENP1 and oncogenic repression have been linked to each other by studies of association.
- The High-Mobility Group-1 family is composed of 4 proteins (HMGA1a, HMGA1b, HMGA1c, and HMGA2), and are involved in cell development. Low levels of HMGA proteins are expressed in adult tissues, and high levels of expression are seen in cells going through embryogenesis. Their importance was further confirmed by doing a knockout study in mice—when HMGA1 was knocked out, development of mice was severely affected (DeMartino et al., 2016). With the importance of HGMA1 in development established, 7 HGMA1 pseudogenes were identified and studied: HMGA1P1, HMGA1P2, HMGA1P3, HMGA1P4, HMGA1P5, HMGA1P6, HMGA1P7, and HMGA1-p. All 8 of the pseudogenes are processed pseudgenes, and found in humans only (DeMartino e al., 2016).
- The HMGA1P1 gene has a mutation at a Protein Kinase C (PKC) phosphorylation site, which results in a significant reduction in DNA binding affinity. HMGA1P2 also affects binding affinity, as well as protein-protein affinity due to an arginine 59 mutation that allows the HMGA1P2 to be methylated by PRMT6, which is another protein-encoding gene. Because of these pseudogenes’ mutations, they can code for competitor proteins for the wild-type HMGA1 gene. Modification of HGMA1 expression results in modified chromatin remodeling and protein-protein (DeMartino et al., 2016). HMGA1P3 lacks the C-terminal acidic tail, which is usually found in most functional and HMGA proteins. The C-terminal acidic tail may play a role in regulating protein-protein interactions and transcription factor activity (DeMartino et al., 2016). Since the C- terminal acidic tail is important in the HGMA protein, HMGA1P3 has reduced function.
- Unlike the HMGA1 pseudogenes described above, pseudogenes HMGA1P4 and HMGA1P5 have low homology with the HGMA1 gene, and is unrelated to the gene itself. HGMA1P4 is wholly untranslatable and can be called a “dead gen”, while HGMA1P5 codes for a peptide completely unrelated to the HMGA1 protein (DeMartino et al., 2016).
- HMGA1P6 contains a mutation in the stop codon, so the gene is extended several amino acids and the corresponding generated mRNA is unable to be translated. The HMGA1P7 is also unable to translate into mRNA, but because the pseudogene has a missense mutation at the start methionine codon (DeMartino et al., 2016). Both HMGA1P6 and HMGA1P7 functions as decoys for HMGA1 targeting miRNAs. By acting as a decoy for the wild-type gene, overexpression of HMGA1P6 and HMGA1P7 also increases levels of expression of the HMGA1 mRNA and protein (Fusco et al., 2016). Inversely, knockdown of the HMGA1P6 and HMGA1P7 pseudogenes result in leads to decreased levels of HMGA1 mRNA and protein (Esposito et al., 2014).
- Because HMGA1 plays an integral part in cell development and is most expressed during embryogenesis, overexpression leads to an overly prolific growth of cells. Overexpression of HMGA1P6 and HMGA1P7 results in overexpression of HMGA1, which has been seen to induce increased migration, invasiveness, and quicker division (Fusco et al., 2016). When transgenic mice containing overexpression of HMGA1P6 and HMGA1P7 were bred, the mice were observed to have significant cancerous activity, proving that overexpression of pseudogenes of HMGA1 are indeed functional and has clear cancerous outcomes. Mouse embryonic fibroblasts (also referred to as MEFs), derived from mice with HMGA1P6 and HMGA1P7 overexpression grew much faster than MEFs derived from wild-type mice (Fusco et al., 2016).
- There is still much to be learned about pseudogenes and their involvement in cancer development and repression, but it is clear that some pseudogenes are in fact not junk, but that they may even be strongly linked to oncogenic development. Different pseudogenes may have different functions and methods to affect the genome, but they interact with the wild-type genes and other genetic elements such as transcription factors to regulate, enhance, or reduce expression of genes.
There an estimated 20,000 pseudo genes in mammalian genomes. A genome-wide survey has discovered functional pseudogenes that are conserved in more than one species.
A bioinformatics analysis has shown that processed pseudogenes can be inserted into introns of annotated genes and be incorporated into alternatively spliced transcripts. This analysis showed strong evidence for transcription of 726 such retrogenes. However, their function was not studied experimentally.
Quite a few pseudogenes can go through the process of transcription, either if their own promotor is still intact or in some cases using the promoter of a nearby gene; this expression of pseudogenes may be tissue-specific. In the bacterium Mycobacterium leprae, 43% of its 1,133 pseudogenes are transcribed (as opposed to 49% overall and 57% of its ORFs). However, that does not make them "functional" in the sense that these genes or proteins have an activity that benefits the organism.
The duplicated pseudogenic DNA can be resurrected to a functional protein in certain cases as a rare or occasional evolutionary event and may enable sampling of more sequence space for a protein or protein family. The pseudogenes or parts of pseudogenes may be re-utilized once they have been drifted randomly without being subjected to selection pressure for certain period of evolution. Koch, for the first time, postulated an idea about such "untranslatable intermediates" in the evolution of protein. Occasionally, this mechanism may yield a shorter evolutionary route to another desirable or favorable evolutionary energetic minimum although one would generally expect it to produce unviable or unfavorable leaps in sequence space. A longer time will be available to search sequence space by the pseudogene resurrection, but it is believed that it rarely brings into existence the proteins with new functions. The repair of lesions could be achieved by the reinsertion of a deleted segment, the removal (in frame) of an inserted segment, or other events that are likely to be improbable like gene conversion. Conversion of a pseudogene with a functional gene as a donor might improve the probability of pseudogene reactivation provided enough of the pseudogene sequence must be preserved throughout the course to maintain the benefits of expanding the sequence space explored after duplication.
There are several examples that can be used to support such resurrection. The bovine seminal ribonuclease, which had lain dormant for about 20 million years as a pseudogene, appears to have been resurrected into a functional gene. It is believed that the event called gene conversion may be the cause of such resurrection. The large group of pseudogenes for olfactory receptors (ORs) in metazoans, where 60% of the ORs in the human genome are pseudogenic, are resurrectable may be due to gene conversion events. In a cluster of ORs which contains 16 OR genes and 6 OR pseudogenes on chromosome 17, is appeared to be subjected to many number (20) of gene conversion events over the course of primate evolution. These gene conversion events in OR gene clusters may aid to bring diversity in binding capability at the odorant binding site. Finally, the resurrection of a pseudogene also led to the diversity of immunoglobulin heavy chain variable-region gene segments in the chicken which appears to be brought by the gene conversion event of a single functional gene with more than 80 pseudogenic gene segments.
The era of molecular paleontology is just beginning. The surface of the pseudogene strata is barely studied, but if scientists conduct more research, they may be able to identify many more pseudogenes. The data mining process of large scale identification of pseudogenes is dynamic. The ancient and decayed pseudogenes are escaping from detection, although the recently generated pseudogenes are readily identified by the current techniques which are heavily based on the sequence comparison to well characterized genes. Characterization of pseudogenes will likely be improved as well since the sequence and annotation of the human genome itself are refined and updated. Modern clues may point to some possibilities of pseudogene resurrection- a dead gene become a living one and making a functional protein exist with the evidence.
In addition to the seminal ribonuclease enzyme, the other incidents like slight differences in the pseudogene complements of individual people have also been found. For instance, in most people the olfactory receptor pseudogenes are dead but in few they are intact and functional genes. Some studies also suggested that however that in yeast, certain cell surface protein pseudogenes are resurrected due to stressful new environment challenged the organism. The two processed pseudogenes called the rat RC9 cytochrome c pseudogene and the mouse L 32 ribosomal protein pseudogene rpL32-4A are implied to be potentially functional. From the recent experiments, they found that in a bacterial genome a considerable segment of the intergenic regions are actively transcribed. From the ENCODE project, scientists have found about 20% of the TARS were produced from previously unidentified ‘potential unborn genes’ which says that there are functional pseudogenes inside these regions. To make sure that do the pseudogenes are transcribed in to RNA and to ascertain their functionality the studies on mouse oocyte are very useful where the small interfering RNAs (siRNAs) derived from pseudogene are found to be functional in regulating gene expression. Some pseudogenes are dead yet with some functions strengthen the fact that they are not ‘junk DNA". With the embedded picture of genome annotation the real evolutionary history of pseudogenes will be revealed out in the near future of research.
- Human disabled pseudogenes list
- Molecular evolution
- Molecular paleontology
- Vanin EF (1985). "Processed pseudogenes: characteristics and evolution". Annual Review of Genetics. 19: 253–72. doi:10.1146/annurev.ge.19.120185.001345. PMID 3909943.
- Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP (June 2010). "A coding-independent function of gene and pseudogene mRNAs regulates tumour biology". Nature. 465 (7301): 1033–8. doi:10.1038/nature09144. PMC . PMID 20577206.
- Herron, Jon C.; Freeman, Scott (2007). Evolutionary analysis (4th ed.). Upper Saddle River, NJ: Pearson Prentice Hall. ISBN 0-13-227584-8.
- Jacq C, Miller JR, Brownlee GG (September 1977). "A pseudogene structure in 5S DNA of Xenopus laevis". Cell. 12 (1): 109–20. doi:10.1016/0092-8674(77)90189-1. PMID 561661.
- Zheng D, Frankish A, Baertsch R, Kapranov P, Reymond A, Choo SW, Lu Y, Denoeud F, Antonarakis SE, Snyder M, Ruan Y, Wei CL, Gingeras TR, Guigó R, Harrow J, Gerstein MB (June 2007). "Pseudogenes in the ENCODE regions: consensus annotation, analysis of transcription, and evolution". Genome Research. 17 (6): 839–51. doi:10.1101/gr.5586307. PMC . PMID 17568002.
- Mighell AJ, Smith NR, Robinson PA, Markham AF (February 2000). "Vertebrate pseudogenes". FEBS Letters. 468 (2-3): 109–14. doi:10.1016/S0014-5793(00)01199-6. PMID 10692568.
- Jurka J (December 2004). "Evolutionary impact of human Alu repetitive elements". Current Opinion in Genetics & Development. 14 (6): 603–8. doi:10.1016/j.gde.2004.08.008. PMID 15531153.
- Dewannieux M, Heidmann T (2005). "LINEs, SINEs and processed pseudogenes: parasitic strategies for genome modeling". Cytogenetic and Genome Research. 110 (1-4): 35–48. doi:10.1159/000084936. PMID 16093656.
- Dewannieux M, Esnault C, Heidmann T (September 2003). "LINE-mediated retrotransposition of marked Alu sequences". Nature Genetics. 35 (1): 41–8. doi:10.1038/ng1223. PMID 12897783.
- Graur D, Shuali Y, Li WH (April 1989). "Deletions in processed pseudogenes accumulate faster in rodents than in humans". Journal of Molecular Evolution. 28 (4): 279–85. doi:10.1007/BF02103423. PMID 2499684.
- Baertsch R, Diekhans M, Kent WJ, Haussler D, Brosius J (October 2008). "Retrocopy contributions to the evolution of the human genome". BMC Genomics. 9: 466. doi:10.1186/1471-2164-9-466. PMC . PMID 18842134.
- Pavlícek A, Paces J, Zíka R, Hejnar J (October 2002). "Length distribution of long interspersed nucleotide elements (LINEs) and processed pseudogenes of human endogenous retroviruses: implications for retrotransposition and pseudogene detection". Gene. 300 (1-2): 189–94. doi:10.1016/S0378-1119(02)01047-8. PMID 12468100.
- Navarro, Fábio C. P.; Galante, Pedro A. F. (2015-08-01). "A Genome-Wide Landscape of Retrocopies in Primate Genomes". Genome Biology and Evolution. 7 (8): 2265–2275. doi:10.1093/gbe/evv142. ISSN 1759-6653. PMC . PMID 26224704.
- Schrider, Daniel R.; Navarro, Fabio C. P.; Galante, Pedro A. F.; Parmigiani, Raphael B.; Camargo, Anamaria A.; Hahn, Matthew W.; Souza, Sandro J. de (2013-01-24). "Gene Copy-Number Polymorphism Caused by Retrotransposition in Humans". PLOS Genet. 9 (1): e1003242. doi:10.1371/journal.pgen.1003242. ISSN 1553-7404. PMC . PMID 23359205.
- Max EE (2003-05-05). "Plagiarized Errors and Molecular Genetics". TalkOrigins Archive. Retrieved 2008-07-22.
- Lynch M, Conery JS (November 2000). "The evolutionary fate and consequences of duplicate genes". Science. 290 (5494): 1151–5. Bibcode:2000Sci...290.1151L. doi:10.1126/science.290.5494.1151. PMID 11073452.
- Walsh JB (January 1995). "How often do duplicated genes evolve new functions?". Genetics. 139 (1): 421–8. PMC . PMID 7705642.
- Lynch M, O'Hely M, Walsh B, Force A (December 2001). "The probability of preservation of a newly arisen gene duplicate". Genetics. 159 (4): 1789–804. PMC . PMID 11779815.
- Harrison PM, Hegyi H, Balasubramanian S, Luscombe NM, Bertone P, Echols N, Johnson T, Gerstein M (February 2002). "Molecular fossils in the human genome: identification and analysis of the pseudogenes in chromosomes 21 and 22". Genome Research. 12 (2): 272–80. doi:10.1101/gr.207102. PMC . PMID 11827946.
- Zhang J (2003). "Evolution by gene duplication: an update.". Trends in Ecology and Evolution. 18 (6): 292–298. doi:10.1016/S0169-5347(03)00033-8.
- Nishikimi M, Kawai T, Yagi K (October 1992). "Guinea pigs possess a highly mutated gene for L-gulono-gamma-lactone oxidase, the key enzyme for L-ascorbic acid biosynthesis missing in this species". The Journal of Biological Chemistry. 267 (30): 21967–72. PMID 1400507.
- Nishikimi M, Fukuyama R, Minoshima S, Shimizu N, Yagi K (May 1994). "Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic acid biosynthesis missing in man". The Journal of Biological Chemistry. 269 (18): 13685–8. PMID 8175804.
- Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, Kim Y, Sabeti P, Chen Y, Stalker J, Huckle E, Burton J, Leonard S, Rogers J, Tyler-Smith C (April 2006). "Spread of an inactive form of caspase-12 in humans is due to recent positive selection". American Journal of Human Genetics. 78 (4): 659–70. doi:10.1086/503116. PMC . PMID 16532395.
- van Baren MJ, Brent MR (May 2006). "Iterative gene prediction and pseudogene removal improves genome annotation". Genome Research. 16 (5): 678–85. doi:10.1101/gr.4766206. PMC . PMID 16651666.
- Harrison PM, Milburn D, Zhang Z, Bertone P, Gerstein M (February 2003). "Identification of pseudogenes in the Drosophila melanogaster genome". Nucleic Acids Research. 31 (3): 1033–7. doi:10.1093/nar/gkg169. PMC . PMID 12560500.
- Long M, Langley CH (April 1993). "Natural selection and the origin of jingwei, a chimeric processed functional gene in Drosophila". Science. 260 (5104): 91–5. Bibcode:1993Sci...260...91L. doi:10.1126/science.7682012. PMID 7682012.
- Hirotsune S, Yoshida N, Chen A, Garrett L, Sugiyama F, Takahashi S, Yagami K, Wynshaw-Boris A, Yoshiki A (May 2003). "An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene". Nature. 423 (6935): 91–6. Bibcode:2003Natur.423...91H. doi:10.1038/nature01535. PMID 12721631.
- Balakirev ES, Ayala FJ (2003). "Pseudogenes: are they "junk" or functional DNA?". Annual Review of Genetics. 37: 123–51. doi:10.1146/annurev.genet.37.040103.103949. PMID 14616058.
- Kawasaki H, Taira K (November 2003). "Retraction: Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells". Nature. 426 (6962): 100. Bibcode:2003Natur.426..100H. doi:10.1038/nature02141. PMID 14603326.
- Gray TA, Wilson A, Fortin PJ, Nicholls RD (August 2006). "The putatively functional Mkrn1-p1 pseudogene is neither expressed nor imprinted, nor does it regulate its source gene in trans". Proceedings of the National Academy of Sciences of the United States of America. 103 (32): 12039–44. Bibcode:2006PNAS..10312039G. doi:10.1073/pnas.0602216103. PMC . PMID 16882727.
- Betrán E, Wang W, Jin L, Long M (May 2002). "Evolution of the phosphoglycerate mutase processed gene in human and chimpanzee revealing the origin of a new primate gene". Molecular Biology and Evolution. 19 (5): 654–63. doi:10.1093/oxfordjournals.molbev.a004124. PMID 11961099.
- Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM, Hannon GJ (May 2008). "Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes". Nature. 453 (7194): 534–8. Bibcode:2008Natur.453..534T. doi:10.1038/nature06904. PMC . PMID 18404147.
- Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata Y, Chiba H, Kohara Y, Kono T, Nakano T, Surani MA, Sakaki Y, Sasaki H (May 2008). "Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes". Nature. 453 (7194): 539–43. Bibcode:2008Natur.453..539W. doi:10.1038/nature06908. PMID 18404146.
- Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP (June 2010). "A coding-independent function of gene and pseudogene mRNAs regulates tumour biology". Nature. 465 (7301): 1033–8. Bibcode:2010Natur.465.1033P. doi:10.1038/nature09144. PMC . PMID 20577206.
- Svensson O, Arvestad L, Lagergren J (May 2006). "Genome-wide survey for biologically functional pseudogenes". PLoS Computational Biology. 2 (5): e46. Bibcode:2006PLSCB...2...46S. doi:10.1371/journal.pcbi.0020046. PMC . PMID 16680195.
- Williams DL, Slayden RA, Amin A, Martinez AN, Pittman TL, Mira A, Mitra A, Nagaraja V, Morrison NE, Moraes M, Gillis TP (2009). "Implications of high level pseudogene transcription in Mycobacterium leprae". BMC Genomics. 10: 397. doi:10.1186/1471-2164-10-397. PMC . PMID 19706172.
- Koch AL (October 1972). "Enzyme evolution. I. The importance of untranslatable intermediates". Genetics. 72 (2): 297–316. PMC . PMID 4567287.
- Sassi SO, Braun EL, Benner SA (April 2007). "The evolution of seminal ribonuclease: pseudogene reactivation or multiple gene inactivation events?". Molecular Biology and Evolution. 24 (4): 1012–24. doi:10.1093/molbev/msm020. PMID 17267422.
- Trabesinger-Ruef N, Jermann T, Zankel T, Durrant B, Frank G, Benner SA (March 1996). "Pseudogenes in ribonuclease evolution: a source of new biomacromolecular function?". FEBS Letters. 382 (3): 319–22. doi:10.1016/0014-5793(96)00191-3. PMID 8605993.
- Sharon D, Glusman G, Pilpel Y, Khen M, Gruetzner F, Haaf T, Lancet D (October 1999). "Primate evolution of an olfactory receptor cluster: diversification by gene conversion and recent emergence of pseudogenes". Genomics. 61 (1): 24–36. doi:10.1006/geno.1999.5900. PMID 10512677.
- Pâques F, Haber JE (June 1999). "Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae". Microbiology and Molecular Biology Reviews. 63 (2): 349–404. PMC . PMID 10357855.
- Gerstein M, Zheng D (August 2006). "The real life of pseudogenes". Scientific American. 295 (2): 48–55. Bibcode:2006SciAm.295b..48G. doi:10.1038/scientificamerican0806-48. PMID 16866288.
- Scarpulla RC (November 1984). "Processed pseudogenes for rat cytochrome c are preferentially derived from one of three alternate mRNAs". Molecular and Cellular Biology. 4 (11): 2279–88. doi:10.1128/mcb.4.11.2279. PMC . PMID 6096691.
- Dudov KP, Perry RP (June 1984). "The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene". Cell. 37 (2): 457–68. doi:10.1016/0092-8674(84)90376-3. PMID 6327068.
- Fu LM, Shinnick TM (2007). "Genome-wide analysis of intergenic regions of Mycobacterium tuberculosis H37Rv using Affymetrix GeneChips". EURASIP Journal on Bioinformatics & Systems Biology. 2007 (1): 23054. doi:10.1155/2007/23054. PMC . PMID 18253472.
- Rozowsky JS, Newburger D, Sayward F, Wu J, Jordan G, Korbel JO, Nagalakshmi U, Yang J, Zheng D, Guigó R, Gingeras TR, Weissman S, Miller P, Snyder M, Gerstein MB (June 2007). "The DART classification of unannotated transcription within the ENCODE regions: associating transcription with known and novel loci". Genome Research. 17 (6): 732–45. doi:10.1101/gr.5696007. PMC . PMID 17567993.
- Gerstein M, Zheng D (August 2006). "The real life of pseudogenes". Scientific American. 295 (2): 48–55. doi:10.1038/scientificamerican0806-48. PMID 16866288.
- Torrents D, Suyama M, Zdobnov E, Bork P (December 2003). "A genome-wide survey of human pseudogenes". Genome Research. 13 (12): 2559–67. doi:10.1101/gr.1455503. PMC . PMID 14656963.
- Bischof JM, Chiang AP, Scheetz TE, Stone EM, Casavant TL, Sheffield VC, Braun TA (June 2006). "Genome-wide identification of pseudogenes capable of disease-causing gene conversion". Human Mutation. 27 (6): 545–52. doi:10.1002/humu.20335. PMID 16671097.